Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000874716-24-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-16 | 2024-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +1,186 | 5,292 | +29% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $560.56 | -356 | 5,112 | -7% | -$199.6K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | -1,186 | 346 | -77% | $0 |
| DM | 2024-02-16 | 2024-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +4,904 | 870 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | A | A | 216 | $0.00 | 4,980.94 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | A | A | 483 | $0.00 | 4,764.94 | D | — | — | (F1) Includes a total of 37.247 shares purchased under the Issuer Employee Stock Purchase Plan on June 30, 2023, September 29, 2023 and December 29, 2023. |
| 3 | Common | Common Stock | 2024-02-14 | A | A | 138 | $0.00 | 5,118.94 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-14 | F | D | 356 | $560.56 | 5,111.94 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-14 | A | A | 176 | $0.00 | 5,467.94 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-14 | A | A | 173 | $0.00 | 5,291.94 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 483 | $0.00 | 0 | D | — · — to — | 483 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 138 | $0.00 | 137 | D | — · — to — | 138 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |
| 9 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-02-14 | A | A | 3,856 | $0.00 | 3,856 | D | $560.56 · — to 2034-02-13 | 3,856 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. |
| 10 | Derivative | Incentive Stock Option (right-to-buy) | 2024-02-14 | A | A | 178 | $0.00 | 178 | D | $560.56 · — to 2034-02-13 | 178 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. |
| 11 | Derivative | Restricted Stock Unit | 2024-02-14 | A | A | 870 | $0.00 | 870 | D | — · — to — | 870 Common Stock | (F4) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. |
| 12 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 176 | $0.00 | 528 | D | — · — to — | 176 Common Stock | (F9) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. |
| 13 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 216 | $0.00 | 0 | D | — · — to — | 216 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021. |
| 14 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 173 | $0.00 | 346 | D | — · — to — | 173 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |